Cargando…

Identification of NAD(+) Metabolism-Derived Gene Signatures in Ovarian Cancer Prognosis and Immunotherapy

Background: Nicotinamide adenine dinucleotide (NAD(+)) has emerged as a critical regulator of cell signaling and survival pathways, affecting tumor initiation and progression. In this study it was investigated whether circulating NAD(+) metabolism-related genes (NMRGs) could be used to predict immun...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Liang, Chen, Li, Xie, Zuolian, Chen, Jian, Li, Ling, Lin, An
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243463/ https://www.ncbi.nlm.nih.gov/pubmed/35783253 http://dx.doi.org/10.3389/fgene.2022.905238

Ejemplares similares

Identification of tumor microenvironment-related signature for predicting prognosis and immunotherapy response in patients with bladder cancer
por: Yao, Zhihao, et al.
Publicado: (2022)

The gene signature of tertiary lymphoid structures within ovarian cancer predicts the prognosis and immunotherapy benefit
por: Hou, Yue, et al.
Publicado: (2023)

Identification of a novel cellular senescence-related signature for the prediction of prognosis and immunotherapy response in colon cancer
por: Dai, Longfei, et al.
Publicado: (2022)

Identification of a nucleotide metabolism-related signature to predict prognosis and guide patient care in hepatocellular carcinoma
por: Li, Yu, et al.
Publicado: (2023)

Identification of a Gene Signature of Cancer-Associated Fibroblasts to Predict Prognosis in Ovarian Cancer
por: Zeng, Li, et al.
Publicado: (2022)

Identification of immune-related signature for the prognosis and benefit of immunotherapy in triple-negative breast cancer
por: Sun, Xiaorui, et al.
Publicado: (2022)

Identification and Validation of a Tumor Microenvironment-Related Gene Signature in Hepatocellular Carcinoma Prognosis
por: Huang, Changjing, et al.
Publicado: (2021)

Identification of Fatty Acid Metabolism-Related lncRNAs as Biomarkers for Clinical Prognosis and Immunotherapy Response in Patients With Lung Adenocarcinoma
por: Wang, Helin, et al.
Publicado: (2022)

Homologous Recombination Related Signatures Predict Prognosis and Immunotherapy Response in Metastatic Urothelial Carcinoma
por: Li, Pan, et al.
Publicado: (2022)

Ferroptosis-Related Gene Signature Predicts the Prognosis of Skin Cutaneous Melanoma and Response to Immunotherapy
por: Xu, Ziqian, et al.
Publicado: (2021)

Identification of Gene Signatures for Diagnosis and Prognosis of Hepatocellular Carcinomas Patients at Early Stage
por: Gan, Xiaoning, et al.
Publicado: (2020)

Identification of a Prognostic Signature for Ovarian Cancer Based on the Microenvironment Genes
por: Huo, Xiao, et al.
Publicado: (2021)

A necroptosis -related signature for predicting prognosis and immunotherapy in hepatocellular carcinoma
por: Fu, Xing, et al.
Publicado: (2022)

Identification and verification of a novel epigenetic-related gene signature for predicting the prognosis of hepatocellular carcinoma
por: Wang, Chenchen, et al.
Publicado: (2022)

Identification of a Recurrence Gene Signature for Ovarian Cancer Prognosis by Integrating Single-Cell RNA Sequencing and Bulk Expression Datasets
por: Zhang, Yongjian, et al.
Publicado: (2022)

Identification of a apoptosis-related LncRNA signature to improve prognosis prediction and immunotherapy response in lung adenocarcinoma patients
por: Luo, Ting, et al.
Publicado: (2022)

Identification of a Pyroptosis-Related Gene Signature for Predicting Overall Survival and Response to Immunotherapy in Hepatocellular Carcinoma
por: Zheng, Susu, et al.
Publicado: (2021)

Impact of NAD+ metabolism on ovarian aging
por: Liang, Jinghui, et al.
Publicado: (2023)

A DNA Damage Repair Gene Signature Associated With Immunotherapy Response and Clinical Prognosis in Clear Cell Renal Cell Carcinoma
por: Peng, Linjie, et al.
Publicado: (2022)

Immune Microenvironment Terms Signature Robustly Predicts the Prognosis and Immunotherapy Response in Bladder Cancer Based on Large Population Cohorts
por: Liang, Shengjie, et al.
Publicado: (2022)

Identification of platinum resistance-related gene signature for prognosis and immune analysis in bladder cancer
por: Li, Sheng, et al.
Publicado: (2023)

Development and Validation of a Novel Gene Signature for Predicting the Prognosis by Identifying m5C Modification Subtypes of Cervical Cancer
por: Yu, Jing, et al.
Publicado: (2021)

A Novel Six-Gene Signature for Prognosis Prediction in Ovarian Cancer
por: Pan, Xin, et al.
Publicado: (2020)

Amino Acid Metabolism-Related lncRNA Signature Predicts the Prognosis of Breast Cancer
por: Dai, Yin-wei, et al.
Publicado: (2022)

Identification of an Autophagy-Related Gene Signature for the Prediction of Prognosis in Early-Stage Colorectal Cancer
por: Lin, Xu-tao, et al.
Publicado: (2021)

Identification and Validation of a PPP1R12A-Related Five-Gene Signature Associated With Metabolism to Predict the Prognosis of Patients With Prostate Cancer
por: Zou, Zhihao, et al.
Publicado: (2021)

Identification of EMT-Related Gene Signatures to Predict the Prognosis of Patients With Endometrial Cancer
por: Cai, Luya, et al.
Publicado: (2020)

Identification of Signatures of Prognosis Prediction for Melanoma Using a Hypoxia Score
por: Shou, Yanhong, et al.
Publicado: (2020)

Construction and validation of a histone acetylation-related lncRNA prognosis signature for ovarian cancer
por: Hu, Xiao-Qian, et al.
Publicado: (2022)

Identification and Validation of a Novel Pyroptosis-Related Gene Signature for Prognosis Prediction in Soft Tissue Sarcoma
por: Qi, Lin, et al.
Publicado: (2021)

A metabolism-related gene signature for predicting the prognosis in thyroid carcinoma
por: Du, Qiujing, et al.
Publicado: (2023)

Identifying a Hypoxia-Related Long Non-Coding RNAs Signature to Improve the Prediction of Prognosis and Immunotherapy Response in Hepatocellular Carcinoma
por: Tang, Pingfei, et al.
Publicado: (2021)

A Novel Pyroptosis-Related Gene Signature for Predicting Prognosis in Kidney Renal Papillary Cell Carcinoma
por: Hu, Jian, et al.
Publicado: (2022)

Identification of a Ubiquitin Related Genes Signature for Predicting Prognosis of Prostate Cancer
por: Song, Guoda, et al.
Publicado: (2022)

Identification and Validation of a Six Immune-Related Genes Signature for Predicting Prognosis in Patients With Stage II Colorectal Cancer
por: Li, Xianzhe, et al.
Publicado: (2021)

Identification of a novel m5C/m6A-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma
por: Ma, Yiming, et al.
Publicado: (2022)

Identification of a Prognostic Signature Associated With DNA Repair Genes in Ovarian Cancer
por: Sun, Hengzi, et al.
Publicado: (2019)

Identification of a Ferroptosis-Related Long Noncoding RNA Prognostic Signature and Its Predictive Ability to Immunotherapy in Hepatocellular Carcinoma
por: Wang, Liang, et al.
Publicado: (2021)

Predicting prognosis and immunotherapy response among colorectal cancer patients based on a tumor immune microenvironment-related lncRNA signature
por: Hu, Chuling, et al.
Publicado: (2022)

Identification of the Six-RNA-Binding Protein Signature for Prognosis Prediction in Bladder Cancer
por: Wu, Yucai, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_f4hpvcgh284ub5nm0uhba2sv60